A Comprehensive Evaluation of Colonic Mucosal Isolates of Sutterella wadsworthensis from Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) arises in genetically susceptible individuals as a result of an unidentified environmental trigger, possibly a hitherto unknown bacterial pathogen. Twenty-six clinical isolates of Sutterella wadsworthensis were obtained from 134 adults and 61 pediatric patients undergoing colonoscopy, of whom 69 and 29 respectively had IBD. S. wadsworthensis was initially more frequently isolated from IBD subjects, hence this comprehensive study was undertaken to elucidate its role in IBD. Utilizing these samples, a newly designed PCR was developed, to study the prevalence of this bacterium in adult patients with ulcerative colitis (UC). Sutterella wadsworthensis was detected in 83.8% of adult patients with UC as opposed to 86.1% of control subjects (p = 0.64). Selected strains from IBD cases and controls were studied to elicit morphological, proteomic, genotypic and pathogenic differences. This study reports Scanning Electron Microscopy (SEM) appearances and characteristic MALDI-TOF MS protein profiles of S. wadsworthensis for the very first time. SEM showed that the bacterium is pleomorphic, existing in predominantly two morphological forms, long rods and coccobacilli. No differences were noted in the MALDI-TOF mass spectrometry proteomic analysis. There was no distinct clustering of strains identified from cases and controls on sequence analysis. Cytokine response after monocyte challenge with strains from patients with IBD and controls did not yield any significant differences. Our studies indicate that S. wadsworthensis is unlikely to play a role in the pathogenesis of IBD. Strains from cases of IBD could not be distinguished from those identified from controls.

[1]  E. El-Omar,et al.  The role of microaerophilic colonic mucosal bacteria in de novo paediatric inflammatory bowel disease , 2011, Gut.

[2]  P. Gerner-Smidt,et al.  Prevalence of Campylobacter,Arcobacter, Helicobacter, andSutterella spp. in Human Fecal Samples as Estimated by a Reevaluation of Isolation Methods for Campylobacters , 2000, Journal of Clinical Microbiology.

[3]  J. Doré,et al.  Molecular inventory of faecal microflora in patients with Crohn's disease. , 2003, FEMS microbiology ecology.

[4]  H. Flint,et al.  Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. , 2002, FEMS microbiology ecology.

[5]  E. El-Omar,et al.  The role of infection in the aetiology of inflammatory bowel disease , 2010, Journal of Gastroenterology.

[6]  E. El-Omar,et al.  Detection of Campylobacter concisus and Other Campylobacter Species in Colonic Biopsies from Adults with Ulcerative Colitis , 2011, PloS one.

[7]  P. Lawson,et al.  Sutterella stercoricanis sp. nov., isolated from canine faeces. , 2004, International journal of systematic and evolutionary microbiology.

[8]  Philippe Marteau,et al.  Bacterial Flora in Inflammatory Bowel Disease , 2010, Digestive Diseases.

[9]  G. D. Inglis,et al.  Comparative genotypic and pathogenic examination of Campylobacter concisus isolates from diarrheic and non-diarrheic humans , 2011, BMC Microbiology.

[10]  Philippe Marteau,et al.  Specificities of the fecal microbiota in inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[11]  Richard Hansen,et al.  Enterohepatic Helicobacter in Ulcerative Colitis: Potential Pathogenic Entities? , 2011, PloS one.

[12]  Peter Lasch,et al.  Identification of Bacillus anthracis by Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Artificial Neural Networks , 2009, Applied and Environmental Microbiology.

[13]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[14]  S. Finegold,et al.  Sources and antimicrobial susceptibilities of Campylobacter gracilis and Sutterella wadsworthensis. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  S. Cucchiara,et al.  Dominant genotypes in mucosa‐associated Escherichia coli strains from pediatric patients with inflammatory bowel disease , 2009, Inflammatory bowel diseases.

[16]  Z. Shen,et al.  Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. , 1998, Gastroenterology.

[17]  M. Alispahic,et al.  Species-specific identification and differentiation of Arcobacter, Helicobacter and Campylobacter by full-spectral matrix-associated laser desorption/ionization time of flight mass spectrometry analysis. , 2010, Journal of medical microbiology.

[18]  M. B. Skirrow,et al.  Campylobacter enteritis: a "new" disease. , 1977, British medical journal.

[19]  Sudhir Kumar,et al.  MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment , 2004, Briefings Bioinform..

[20]  R. Tanaka,et al.  Sutterella parvirubra sp. nov. and Megamonas funiformis sp. nov., isolated from human faeces. , 2008, International journal of systematic and evolutionary microbiology.

[21]  R. Kolínská,et al.  Species identification of Campylobacter jejuni ssp. jejuni and C. coli by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and PCR , 2008, Folia Microbiologica.

[22]  Si Ming Man,et al.  Detection and Isolation of Campylobacter Species Other than C. jejuni from Children with Crohn's Disease , 2008, Journal of Clinical Microbiology.

[23]  K. Wilson,et al.  Sutterella wadsworthensis gen. nov., sp. nov., bile-resistant microaerophilic Campylobacter gracilis-like clinical isolates. , 1996, International Journal of Systematic Bacteriology.

[24]  G. Williamson,et al.  Esterase activity able to hydrolyze dietary antioxidant hydroxycinnamates is distributed along the intestine of mammals. , 2001, Journal of agricultural and food chemistry.

[25]  T. Maier,et al.  Direct bacterial profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for identification of pathogenic Neisseria. , 2009, The Journal of molecular diagnostics : JMD.

[26]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[27]  G. Hold,et al.  Biochemical Characterization of Sinorhizobium meliloti Mutants Reveals Gene Products Involved in the Biosynthesis of the Unusual Lipid A Very Long-chain Fatty Acid* , 2011, The Journal of Biological Chemistry.

[28]  J. Espín,et al.  Interaction between phenolics and gut microbiota: role in human health. , 2009, Journal of agricultural and food chemistry.